Table 3 Associations between markers and chemotherapy response.

From: Immunological tumor status may predict response to neoadjuvant chemotherapy and outcome after radical cystectomy in bladder cancer

Variable

 

Complete vs. other

Complete/Partial vs. other

Other vs. progression

HR

95% CI

p-value

HR

95% CI

p-value

HR

95% CI

p-value

CD68

Low vs. high

0.72

0.27–1.91

0.50

1.13

0.42–3.023

0.81

1.63

0.52–5.078

0.40

Continuous

0.33

0.58

0.97

MAC387

Low vs. high

0.94

0.36–2.49

0.91

1.038

0.39–2.77

0.94

1.48

0.49–4.46

0.48

Continuous

0.42

0.40

0.53

MAC387tumor1

Low vs. high

3.57

0.90–14.13

0.070*

3.18

0.97–10.37

0.056*

3.76

1.10–12.82

0.034*

All groups 0–3

0.41

0.36

0.40

CLEVER-1m2

Low vs. high

1.63

0.62–4.32

0.33

2.78

1.006–7.67

0.049*

1.61

0.53–4.88

0.40

Continuous

0.49

0.21

0.88

CLEVER-1v3

Low vs. high

0.99

0.37–2.62

0.98

0.76

0.28–2.050

0.58

0.47

0.14–1.52

0.21

Continuous

0.26

0.10

0.012*

  1. Regression analyses were used to evaluate the association between the chemotherapy response and marker groups dichotomized according to the mean value. Mann-Whitney U test was used to evaluate the association between the continuous variables and chemotherapy response. Pearson Chi-square/Fisher’s exact test was used to evaluate the association between MAC387+ tumor cells and chemotherapy response.
  2. 1MAC387 positive tumor cells; low (score 0–2), high (score 3).
  3. 2CLEVER-1 positive macrophages.
  4. 3CLEVER-1 positive vessels.
  5. *Significant p-value.